Giant Cell Arteritis and Polymyalgia Rheumatica: Pathophysiology and Management

ISSN： 1170-229X

Source： Drugs & Aging, Vol.23, Iss.8, 2006-01, pp. : 627-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymyalgia Rheumatica and Giant Cell Arteritis in Older Patients: Diagnosis and Pharmacological Management

By Schmidt Jean Warrington Kenneth J.

Drugs & Aging, Vol. 28, Iss. 8, 2011-08 ,pp. : 651-666

Adis International

Access to resources Recommend Favorite

Polymyalgia rheumatica and its links with giant cell arteritis

By Charlton Rodger

Clinical Medicine, Vol. 8, Iss. 5, 2008-10 ,pp. : 498-501

Royal College Of Physicians

Access to resources Recommend Favorite

Corticosteroids are essential when treating patients with giant cell arteritis or polymyalgia rheumatica

Drugs & Therapy Perspectives, Vol. 28, Iss. 4, 2012-04 ,pp. : 11-14

Adis International

Access to resources Recommend Favorite

Influenza virus vaccine: Giant cell arteritis with polymyalgia rheumatica in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Medical management of polymyalgia rheumatica

By Gonzalez-Gay Miguel A Agudo Mario Martinez-Dubois Cristina Pompei Orlando Blanco Ricardo

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1077-1087

Informa Healthcare

Access to resources Recommend Favorite